Dayarn Pharma, founded in 2010 and headquartered in Dubai, is a multi-national style organisation with the aim to deliver the highest quality standards of sales, marketing and regulatory activities needed to maximise brands in the pharmaceutical and healthcare markets across the MENA Region.

We manage all the steps needed to bring new and unregistered products to market. We deliver regulatory approval for each country in a region that is complex and fragmented. We work with a selection of the top 5 distributors in each country to ensure we choose the 'best fit' for logistics support for a given product.

These activities, together with our understanding of the markets, pave the way for us to develop and adapt effective marketing strategies for each brand we represent. We deliver the most effective operational plans possible to ensure the brand succeeds.

Our success is based on employing and training the highest quality people from multinational companies. We're proud of our team and they are one of the reasons Dayarn Pharma is now a trusted and reliable partner to several multinationals in the region.

Mission Statement

To deliver the highest quality sales, marketing and regulatory organisation to maximise pharmaceutical and healthcare brands to their full potential. To be the partner of choice for multinational pharmaceutical and healthcare companies in the MENA Region.

Board of Directors

Omar Khan
Dayarn Pharma (CEO)
Riyad Alhoraibi
Asas Capital (CEO)
Abdullah Saleh Al-Alamoudi
Alamoudi United Company (Chairman)
Adil Zaman
Dayarn Pharma (Marketing Director)

Omar Khan (Founder & CEO)

Dayarn Pharma (CEO)

Omar Khan has over 30 years of experience in pharmaceuticals in senior strategic and operational posts. Prior to Dayarn Pharma, he was Head of Marketing and Sales Middle East, Africa and Eastern Europe for Novartis. Previous to this, Omar was with Boehringer Ingelheim (BI) in a variety of roles. He was Head of Sales for BI UK, before being promoted to Head of UK Strategic Operations. Following his UK success, Omar was posted to BI HQ in German, where he held a number of positions; As Regional Business Manager he was responsible for delivering the P&L for the Middle East, Africa, Pakistan and Taiwan operative units. Omar then moved to Alliance Lead for Africa, Asia, Australasia and Japan (AAA region) for Boehringer's co-promotion deals with Lilly and Pfizer. He was accountable for the successful commercialisation of the co-promotion molecules across AAA region. Omar began his career at Eli Lilly and holds a degree in Biochemistry from Royal Holloway College, London, and an MBA from Durham University Business School.

Adil Zaman (Marketing Director)

Dayarn Pharma (Marketing Director)

Adil Zaman has over 25 years of experience in pharmaceuticals in regional, director­level posts. He has been with Dayarn Pharma as Marketing Director from day one. Prior to this he was Marketing Director for Pfizer in Pakistan having joined the company as a Sales Director, where he helped to establish and grow a 100 million dollar business with a national team of over 500 employees. In addition to his senior operational roles he helped shape the strategic direction for Pfizer Pakistan as a Board Member. Adil was involved in number of regional initiatives driven by the Hong Kong Regional Office to help shape Pfizer's long term Asia strategy. Adil played a key role in a number of strategic planning initiatives across Asia. Prior to this he was head of Consumer Healthcare with Parke Davis. He began his career with ICI Pharmaceuticals.

Riyad Alhoraibi (Board Director)

Asas Capital (CEO)

Riyad Alhoraibi has over 15 years of successful experience in Venture Capital and Private equity investment and is CEO and Co­Founder of Asas Capital, an Asset Management Investment company based in Dubai. He is also the Managing Director of Sahara Global Investment in Dubai and a member of the board for a number companies in KSA, UAE and the Middle East, including: Zad Modern Company and Noon Real Estate in Saudi Arabia and the Coral Aden Hotel and Gulf Aden Fisheries in Yemen. Riyad holds a BA in Economics from KAAU, Jeddah, and an MBA (American University of Sharjah).

Shk. Abdullah Saleh Al-Alamoudi (Board Director)

Alamoudi United Company (Chairman)

Shk. Abdullah Saleh Al­Alamoudi is a leading industrialist in the Middle East with over 30 years of experience in a variety of business roles. His current posts include:Chairman and partner of Alamoudi United Company; Chairman and Partner of Alamoudi Beverage Industries company; member of the board of Saudi Red Bricks Co and Chairman and Partner of Dalil Turkeya. His is also owner of Rhodes Establishment, an Agricultural Services company in Saudi Arabia, and owner of the real estate development company, Abdullah Alamoudi Consultant Office. He holds a BA in Architecture from Kansas State University.